PULMONARY FUNCTION REPORT                          Name:

                                                                                          U nit No:                  Age: 17

                                                                                          Gender:              F

                                                                                          D.O.B.

Smoker: N                                                                           H eight (cm):            164 Wt (kg):47.0 BMI: 17

                                                                                          A.M.0.             

Pack‑years Smoked: 0.0                                                       Source:

 

Provisional Diagnosis: ?ASTHMA

Bronchodilator Dose: BRICANYL + ATROVENT MD1 1 MG/80 UG

 

SPIROMETRY

 

Arterial Blood Gas

                                  Pre-Dilator % Predicted

Post-Dilator % Predicted

F 102 (%)

 

FEV1 (ml BTPS)   2770              92

3050                        102

Pa02

 

FVC (ml BTPS)     3670             105

3950                        11

PaC02 (mm.Hg)

 

FEV1 /VC(%)                   75

77

pH

 

PEFR (L/sec)          6.1                89

6.3                            93

HC03

 

FEF25-75 (L/sec)   2. 3                63

2.5                           67

BE

 

 

 

 

 

Single Breath Diffusion Capacity for Carbon Monoxide

Sa02 (%)

 

 

Observed % Predicted

A-a -grad.(mmHg)

 

DLCO

 

Hb (g/L)

 

KCO

 

CO Hb

 

Alveolar Volume

 

 

 

 

 

 

 

LUNG VOLUMES ml BTPS (Closed circuit - Helium dilution)

 

 

Predicted

Observed % Predicted

Total Lung Capacity

4452                 

                           5641

127

Vital Capacity (slow)

3492

                           3953

113

Inspiratory Capacity

2367

                           2196

93

Functional Residual Capacity

2085

                           3445

165

Residual Volume

960

                           1688

176